BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
Tony Caggiano, MD, PhD, Chairman
Current Chief Medical Officer and Head of R&D at Neurotrauma Sciences and former Vice President of R&D at Acorda Therapeutics. Dr. Caggiano’s responsibilities include leading the research, development, manufacturing, preclinical testing and early phase clinical planning.
Carrolee Barlow, MD, PhD
Current Chief Medical Officer of E-Scape Bio and former CEO of The Parkinson’s Institute and Clinical Center. Dr. Barlow was a former Merck executive who now serves on SABs and as a consultant for biotech companies.
Bob Brown, JD, DPhil, MD
Professor and Chair of Neurology at the University of Massachusetts Medical Center and Medical School. Dr. Brown led the team that identified the first gene linked to ALS, SOD1.
Tom Carmichael, MD, PhD
Chair and Professor of Neurology at the Geffen School of Medicine at UCLA. Dr. Carmichael has an active laboratory and clinical interests in stroke and neurorehabilitation and how the brain recovers from injury.
Steven C. Cramer, MD, MMSc
Professor of Neurology at the University of California–Irvine School of Medicine, Professor in the Department Anatomy & Neurobiology at UCI and Professor in the Department Physical Medicine & Rehabilitation. Dr. Cramer’s research involves CNS Repair in Humans; Stroke; Spinal Cord Injury; Motor System; Plasticity after CNS Injury; Brain Imaging.
Seth Finkelstein, MD, PhD
Current Neurologist at MGH and former Head of CMS Growth Factor Research Lab at MGH and Associate Professor at Harvard Medical School. Dr. Finkelstein is the former VP and Head of Neuroscience Division at Viacell, Inc., and current CEO at Stemetix, Inc.
Greg Licholai, MD, MBA
Chief Medical and Information Officer at PRA Health Sciences and former President and Chief Medical Officer of Castle Creek Pharmaceuticals. Founder and President of Elipdera Therapeutics at Moderna.
Darryl Patrick, PhD, DVM
Over 25 years R&D experience as former Merck and Vertex VP responsible for preclinical safety programs, Toxicology, Drug Metabolism, and Clinical Pharmacology. Dr. Patrick retired in 2011 and currently consulting.
Thomas Voit, MD
Current Director Designate of the Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and the Institute of Child Health, University College London.
Thomas Walther, PhD
Chair in Pharmacology and Head of the Department of Pharmacology and Therapeutics at the University College Cork. Professor Walther’s research helped discover the role of Angiotensin (1-7) as a ligand to the Mas receptor.